
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease. https://ift.tt/3fkqXKY
Hiç yorum yok:
Yorum Gönder